Novel risk score of contrast‐induced nephropathy after percutaneous coronary intervention

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1797|20|8|544-551

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.20, Iss.8, 2015-08, pp. : 544-551

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Contrast-Induced Nephropathy in Percutaneous Coronary Interventions: Pathogenesis, Risk Factors, Outcome, Prevention and Treatment

By  

Cardiology, Vol. 128, Iss. 1, 2014-02 ,pp. : 62-72

Karger

Access to resources Recommend Favorite

Urinary IL-18 and NGAL as Early Predictive Biomarkers in Contrast-Induced Nephropathy after Coronary Angiography

By  

Nephron Clin Pract, Vol. 108, Iss. 3, 2008-02 ,pp. : c176-c181

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitors as a Risk Factor for Contrast-Induced Nephropathy

By  

Nephron Clin Pract, Vol. 104, Iss. 1, 2006-05 ,pp. : c20-c27

Karger

Access to resources Recommend Favorite

Incidence, prognostic impact, and optimal definition of contrast‐induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all‐comer PRODIGY trial

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 1, 2015-07 ,pp. : E19-E27

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low-Dose Furosemide Administered with Adequate Hydration Reduces Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography

By  

Cardiology, Vol. 125, Iss. 2, 2013-05 ,pp. : 69-73

Karger

Access to resources Recommend Favorite